Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Positive late stage results pave the way for Medivation and Astellas to expand Xtandi's label, putting it even more directly in competition with Johnson's Zytiga.
Medivation Still Prevailing
New data on Medivation's Xtandi still makes it look better than Johnson & Johnson's Zytiga and Dendreon's Provenge.
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Sales momentum for Johnson & Johnson's (JNJ) Zytiga is slowing in the United States as competitor Medivation (MDVN) jockeys for position.